Antivascular Endothelial Growth Factors for the Management of Choroidal Neovascularization Associated with Choroidal Osteoma: A Case Study-Based Review
Anti-VEGF agents, like bevacizumab, appear to be a promising treatment option for CNV secondary to choroidal osteoma, potentially preserving and improving vision with limited injections.
Authors
- Sahba Fekri (ORCID: https://orcid.org/0000-0002-7388-6725)
- Azadeh Farahi
- Maryam Zamani (ORCID: https://orcid.org/0000-0003-0120-573X)
Institutions
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Current Ophthalmology
- Published
- 2024-10-01
- DOI
- https://doi.org/10.4103/joco.joco_74_24
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00